Dose Escalation Study of BIBF 1120 in Patients With Advanced Gynaecological Malignancies
Boehringer Ingelheim
Boehringer Ingelheim
Advaxis, Inc.
Catalysis SL
GamaMabs Pharma
Hoffmann-La Roche
Novartis
Tesaro, Inc.
Eli Lilly and Company
Eli Lilly and Company
Eli Lilly and Company
Amgen
Eli Lilly and Company